Cefaclor

dosage;

250 mg every 8 hours, doubled for severe infections; max. 4g daily;

Child over 1 month, 20 mg/kg daily in 3 divided doses,

doubled for severe infections, max. 1 g daily; or 1 month-

Child1 year, 62.5 mg every 8 hours;

1-5 years, 125 mg;

Child over 5 years, 250 mg; doses doubled for severe infections.

Cefaclor Brands

Brand Name Manufacturer Name Distributor Drug Strength Packaging Formulation Formulation Strength Price
Ceclor Eli Lilly & Co. Statim Pharmaceuticals Ltd 375mg 10 Tablet per tablet KES 1,049.70
Ceclor Eli Lilly & Co. Statim Pharmaceuticals Ltd 125mg 75ml Dry Syrup per 5ML KES 629.80
Ceclor Eli Lilly & Co. Statim Pharmaceuticals Ltd 250mg 75ml Dry Syrup per 5ML KES 1,078.90
Ceclor Eli Lilly & Co. Statim Pharmaceuticals Ltd 375mg 50ml Dry Syrup per 5ML KES 1,078.90
Halocef Aristo Pharmaceuticals Ltd. British Pharmaceuticals Ltd 125mg 100ml Suspension per 5ML KES 520.00
Labclor Laboratory & Allied Ltd. Laboratory & Allied Ltd 250mg 10 Capsule per capsule KES 295.00
Labclor Laboratory & Allied Ltd. Laboratory & Allied Ltd 500mg 10 Capsule per capsule KES 295.00
Vercef Ranbaxy 375mg 10s tablet per tab KES 752

Cefaclor more info

Mode Of Action

Inhibits synthesis of bacterial cell wall, causing cell death, hence bactericidal. required.

Drug Indication Respiratory tract infections, otitis media, skin and tissues infections and other infections caused by susceptible micro-organisms.
Precautions Impaired renal functions, penicillin cross sensitivity
Contra-Indications Sensitivity to cephalosporins.
Side Effects Diarrhoea and rarely antibiotic-associated colitis, nausea and vomiting, abdominal discomfort, headache; allergic reactions including rashes, pruritus, urticaria, serum sickness-like reactions with rashes, fever, arthralgia and anaphylaxis; Stevens-Johnson syndrome, toxic epidermal necrolysis; disturbances in liver enzymes, transient hepatitis and cholestatic jaundice; other side-effects reported include eosinophilia and blood disorders (including thrombocytopenia, leucopenia, agranulocytosis, a
Dosage 250 mg every 8 hours, doubled for severe infections; max. 4g daily; child over 1 month, 20 mg/kg daily in 3 divided doses, doubled for severe infections, max. 1 g daily; or 1 month-1 year, 62.5 mg every 8 hours; 1-5 years, 125 mg; over 5 years, 250 mg; doses doubled for severe infections.
Pregnancy Category Category B1
Pregnancy Category Description Drugs which have been taken by only a small number of pregnant women and women of child-bearing age with no any established rise in the frequency of malformations or other direct or indirect detrimental effects on the foetus having been noted. Studies in animals have not shown evidence of an increased occurrence of foetal damage.
Drug Category DRUGS ACTING ON INFECTIONS
Drug Sub-Category Cephalosporins